국소 진행성 위암에서의 보조적 PD-1/PD-L1 억제제와 화학요법: 체계적 검토 및 메타 분석

Li 외(2023)는 이 질문을 연구했습니다.

www.synapsesocial.com/papers/69a75f3ac6e9836116a2a775 — DOI: https://doi.org/10.1016/j.critrevonc.2026.105166

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer· 2006 · 6,349 citations
2. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study· 2023 · 329 citations
3. Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial· 2025 · 12 citations
4. Chemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction Adenocarcinoma· 2023 · 22 citations
5. Comprehensive multi‐omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single‐center, open‐label, single‐arm phase II trial· 2024 · 18 citations